<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/18649" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/18649/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/18649/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_18649"><akn:num>18649</akn:num><akn:heading>Isotope research, development, and production</akn:heading><akn:content><akn:p>§ 18649. Isotope research, development, and production(a) Definition of critical radioactive and stable isotope(1) In generalIn this section, the term “critical radioactive and stable isotope” means a radioactive and stable isotope—(A) the domestic commercial production of which is unavailable or inadequate to satisfy the demand of research, medical, industrial, or related industries in the United States; and

(B) the supply of which is augmented through—(i) Department production; or

(ii) foreign suppliers.



(2) ExclusionIn this section, the term “critical radioactive and stable isotope” does not include the medical isotope molybdenum-99, the production and supply of which is addressed in the American Medical Isotopes Production Act of 2012 (Public Law 112–239; 126 Stat. 2211) (including the amendments made by that Act).



(b) ProgramThe Director shall—(1) carry out, in coordination with other relevant programs across the Department, a program—(A) for the production of critical radioactive and stable isotopes, including the development of techniques to produce isotopes, that the Secretary determines are needed and of sufficient quality and quantity for research, medical, industrial, or related purposes;

(B) for the production of critical radioactive and stable isotopes that are in short supply or projected to be in short supply in the future, including byproducts, surplus materials, and related isotope services;

(C) to maintain and enhance the infrastructure required to produce and supply critical radioactive and stable isotope products and related services;

(D) to conduct research and development on new and improved isotope production and processing techniques that can make critical radioactive and stable isotopes available for research and application as soon as possible while assisting in workforce development;

(E) to reduce domestic dependency on the foreign supply of critical radioactive and stable isotopes to ensure national preparedness; and

(F) to t</akn:p></akn:content><akn:subsection eId="subsec_18649_a"><akn:num>(a)</akn:num><akn:heading>Definition of critical radioactive and stable isotope</akn:heading><akn:content><akn:p>(a) Definition of critical radioactive and stable isotope</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18649_b"><akn:num>(b)</akn:num><akn:heading>Program</akn:heading><akn:content><akn:p>(b) Program The Director shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18649_c"><akn:num>(c)</akn:num><akn:heading>Advisory committee</akn:heading><akn:content><akn:p>(c) Advisory committee</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18649_d"><akn:num>(d)</akn:num><akn:heading>Report</akn:heading><akn:content><akn:p>(d) Report</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_18649_e"><akn:num>(e)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(e) Authorization of appropriations Out of funds authorized to be appropriated for the Office of Science in a fiscal year, there are authorized to be appropriated to the Secretary to carry out this section—</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>